Antibody drug conjugates: hitting the mark in pancreatic cancer?
Abstract Pancreatic cancer is one of the most common causes of cancer-related death, and the 5-year survival rate has only improved marginally over the last decade. Late detection of the disease means that in most cases the disease has advanced locally and/or metastasized, and curative surgery is no...
Furkejuvvon:
| Váldodahkkit: | , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
BMC
2023-10-01
|
| Ráidu: | Journal of Experimental & Clinical Cancer Research |
| Fáttát: | |
| Liŋkkat: | https://doi.org/10.1186/s13046-023-02868-x |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|